These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3067744)

  • 1. The 12-hour control of intraocular pressure on carteolol 2% twice daily.
    Duff GR; Newcombe RG
    Br J Ophthalmol; 1988 Dec; 72(12):890-1. PubMed ID: 3067744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-masked comparison of carteolol and timolol in ocular hypertension.
    Scoville B; Mueller B; White BG; Krieglstein GK
    Am J Ophthalmol; 1988 Feb; 105(2):150-4. PubMed ID: 3277436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tolerance and pharmacologic effectiveness of antiglaucoma eyedrops].
    Flury H; Tournoux A; Martenet AC
    Klin Monbl Augenheilkd; 1986 Jun; 188(6):573-5. PubMed ID: 3761959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-crossover trial comparing the effects of topical carteolol and placebo on intraocular pressure.
    Duff GR; Graham PA
    Br J Ophthalmol; 1988 Jan; 72(1):27-8. PubMed ID: 3277664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of beta-blocking agent carteolol on healthy volunteers and glaucoma patients (author's transl)].
    Negishi C; Ueda S; Kanai A; Nakajima A; Funahashi M; Kitazawa Y; Komemushi S
    Nippon Ganka Gakkai Zasshi; 1981 Jan; 85(1):57-66. PubMed ID: 6114632
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypotensive effect of carteolol on intraocular pressure elevation and secondary glaucoma associated with endogenous uveitis.
    Ohno S; Ichiishi A; Matsuda H
    Ophthalmologica; 1989; 199(1):41-5. PubMed ID: 2761985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 3-month comparison of 1% and 2% carteolol and 0.5% timolol in open-angle glaucoma.
    Stewart WC; Shields MB; Allen RC; Lewis RA; Cohen JS; Hoskins HD; Hetherington JN; Bahr RL; Noblin JE; Delehanty JT
    Graefes Arch Clin Exp Ophthalmol; 1991; 229(3):258-61. PubMed ID: 1869063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the effects of timolol and epinephrine on intraocular pressure.
    Moss AP; Ritch R; Hargett NA; Kohn AN; Smith H; Podos SM
    Am J Ophthalmol; 1978 Oct; 86(4):489-95. PubMed ID: 360846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ocular hypotensive effects of carteolol hydrochloride in primary open-angle glaucoma and ocular hypertensive patients. A double-masked cross-over study for the determination of concentrations optimal for the clinical use (author's transl)].
    Kitazawa Y; Azuma I; Takase M; Komemushi S
    Nippon Ganka Gakkai Zasshi; 1981; 85(7):798-804. PubMed ID: 7030018
    [No Abstract]   [Full Text] [Related]  

  • 10. A study of the intraocular pressure lowering effect of timolol and dipivalyl epinephrine.
    Frumar KD; McGuinness R
    Trans Ophthalmol Soc N Z; 1981; 33():27-9. PubMed ID: 7020221
    [No Abstract]   [Full Text] [Related]  

  • 11. [Aqueous humor flow measured by fluorophotometry. A comparative study of the effect of various beta-blocker eyedrops in patients with ocular hypertension].
    Coulangeon LM; Sole M; Menerath JM; Sole P
    Ophtalmologie; 1990; 4(2):156-61. PubMed ID: 2235007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of topical and oral timolol in glaucoma.
    Batchelor ED; O'Day DM; Shand DG; Wood AJ
    Ophthalmology; 1979 Jan; 86(1):60-5. PubMed ID: 394062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of the intraocular pressure lowering effect of timolol and dipivalyl epinephrine.
    Frumar KD; McGuinness R
    Aust J Ophthalmol; 1982 May; 10(2):121-3. PubMed ID: 7049141
    [No Abstract]   [Full Text] [Related]  

  • 14. A blind randomised cross-over trial comparing metipranolol 0.3% with timolol 0.25% in open-angle glaucoma: a pilot study.
    Mills KB; Wright G
    Br J Ophthalmol; 1986 Jan; 70(1):39-42. PubMed ID: 2868753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular and cardiovascular response to topical carteolol 2% and timolol 0.5% in healthy volunteers.
    Brazier DJ; Smith SE
    Br J Ophthalmol; 1988 Feb; 72(2):101-3. PubMed ID: 3349009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of timolol and adrenaline.
    Ohrström A; Kättström O
    Br J Ophthalmol; 1981 Jan; 65(1):53-5. PubMed ID: 7004479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of timolol maleate to routine medical therapy: a clinical trial.
    Smith RJ; Nagasubramanian S; Watkins R; Poinoosawmy D
    Br J Ophthalmol; 1980 Oct; 64(10):779-81. PubMed ID: 7000172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Betaxolol vs timolol. A six-month double-blind comparison.
    Stewart RH; Kimbrough RL; Ward RL
    Arch Ophthalmol; 1986 Jan; 104(1):46-8. PubMed ID: 3510612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timolol plus maximum-tolerated antiglaucoma therapy.
    Zimmerman TJ; Gillespie JE; Kass MA; Yablonski ME; Becker B
    Arch Ophthalmol; 1979 Feb; 97(2):278-9. PubMed ID: 399180
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experiences in a double-blind study with different concentrations of timolol and pilocarpine (author's transl)].
    Merté HJ; Merkle W
    Klin Monbl Augenheilkd; 1980 Oct; 177(4):443-50. PubMed ID: 7019558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.